| abstract |
The invention provides novel benzoimidazolone-carboxamide-derived carbamate 5-HT 4 receptor agonist compounds of formula (I): n nwherein R 1 , R 2 , R 3 , R 4 , a, and b are defined in the disclosure. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT 4 receptor activity, and processes and intermediates useful for preparing such compounds. |